Skip to content Skip to footer

First Medicare-Accepted Oral Appliance Treatment for All Severities of Obstructive Sleep Apnea in Adults   LITTLETON, Colo., April 9, 2024 — Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS),…

Vivos management to present at 11:45 am Eastern Time on November 17, 2021 HIGHLANDS RANCH Colorado, December 9, 2021 Vivos Therapeutics, Inc. (“Vivos” or the “Company”) (NASDAQ: VVOS), a medical technology…

Third Quarter Revenue Increased Over 38% Year-Over-Year Expects to Benefit from Increased OSA Testing, Opening of Live Training Facility, Expansion of Marketing Programs, Additional FDA Approval and Positive Study Results…

Vivos management to present at 11:45 am Eastern Time on November 17, 2021 HIGHLANDS RANCH Colorado, November 15, 2021 Vivos Therapeutics, Inc. (“the Company”) (NASDAQ: VVOS), a medical technology company…

Call Scheduled for Monday, November 15, 2021 at 5:00 pm ET HIGHLANDS RANCH   Colorado, November 9, 2021 Vivos Therapeutics, Inc. (the “Company” or “Vivos”) (NASDAQ:VVOS), a medical technology company…

Vivos management to present at 12:15 pm Eastern Time on October 27, 2021 HIGHLANDS RANCHColorado, October 25, 2021 Vivos Therapeutics, Inc. (the “Company” or “Vivos”) (NASDAQ:VVOS), a medical technology company…

HIGHLANDS RANCHColorado, October 18, 2021 Vivos Therapeutics, Inc. (the “Company” or “Vivos”) (NASDAQ:VVOS), a medical technology company focused on developing and commercializing innovative diagnostic and treatment modalities for patients suffering…

HIGHLANDS RANCHColorado, October 13, 2021 Vivos Therapeutics, Inc. (the “Company” or “Vivos”) (NASDAQ:VVOS), a medical technology company focused on developing and commercializing innovative diagnostic and treatment modalities for patients suffering…

If Approved for Clearance, Vivos’ Updated Device Will Treat Mild to Moderate Sleep Apnea and Expand Insurance Reimbursement to include Medicare Coverage HIGHLANDS RANCH Colorado, September 29, 2021   Vivos Therapeutics,…

What’s Trending

Vivos Therapeutics’ Flagship CARE Oral Medical Devices Receive Full Approval for Medicare Reimbursement

Vivos Therapeutics’ Flagship CARE Oral Medical Devices Receive Full Approval for Medicare Reimbursement

Vivos Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Operational Update

Tags